Alternatives to Denali Therapeutics

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Developing novel therapies for neurological disorders.

Restores glutamate homeostasis by targeting astrocyte biology, breaking the cycle of excitotoxicity across CNS diseases.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

A biotechnology company developing genetic therapies for rare disorders.

Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.

Prophet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.

AI-guided drug discovery platform for tissue-targeted medicines.

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Sinaptica Therapeutics is a biotechnology company developing novel therapies for neurodegenerative diseases, focusing on synaptic dysfunction.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops and manufactures biologics for therapeutic applications.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.